Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.81 and traded as high as $0.9132. Medicure shares last traded at $0.85, with a volume of 10,000 shares changing hands.
Medicure Price Performance
The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04. The business has a 50-day simple moving average of $0.76 and a 200 day simple moving average of $0.81. The firm has a market cap of $8.87 million, a P/E ratio of -1.81 and a beta of 0.99.
Medicure (OTCMKTS:MCUJF – Get Free Report) last issued its quarterly earnings data on Thursday, May 21st. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01. The firm had revenue of $5.79 million for the quarter, compared to analyst estimates of $3.63 million. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Featured Articles
- Five stocks we like better than Medicure
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
